Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL27646773 | 0.84 | PPARD (0.44) | PPARDTSHRTP53TDP1CA12 | |
| Trifluoromethanesulfonic Acid SCHEMBL5026579 | 0.83 | TSHR (0.37) | PPARDTSHRTP53TDP1CA12 | |
| Diethyl Hydrogen Phosphate SCHEMBL29130692 | 0.82 | PPARD (0.34) | PPARDTSHRTP53TDP1 | |
| Diethyl Hydrogen Phosphate SCHEMBL19812734 | 0.82 | TSHR (0.43) | PPARDTSHRTP53TDP1CA12 | |
| Diethyl Hydrogen Phosphate SCHEMBL27745742 | 0.80 | TSHR (0.42) | PPARDTSHRTP53TDP1LPAR1 | |
| Diethyl Hydrogen Phosphate SCHEMBL31413319 | 0.79 | TP53 (0.52) | PPARDTSHRTP53TDP1CA12 | |
| Diethyl Hydrogen Phosphate SCHEMBL27641870 | 0.79 | TSHR (0.50) | PPARDTSHRTP53TDP1CA12 | |
| Diethyl Hydrogen Phosphate SCHEMBL93056 | 0.79 | — | — | |
| Diethyl Hydrogen Phosphate SCHEMBL27294237 | 0.79 | TSHR (0.56) | PPARDTSHRTP53TDP1CA12 | |
| Diethyl Hydrogen Phosphate SCHEMBL23012595 | 0.77 | TSHR (0.48) | PPARDTSHRTP53TDP1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260121095-A1 | Advanced Ion Exchange Membranes And Applications Thereof | WILLIAMS RICHARD KENT (US) | 2026-04-30 | — | — | US | disclosed |
| WO-2025128460-A1 | ADVANCED ION EXCHANGE MEMBRANES AND APPLICATIONS THEREOF | WILLIAMS RICHARD KENT (US) | 2025-06-19 | — | — | WO | disclosed |
| EP-2655496-B1 | THERMOPLASTIC MOLDING COMPOSITION | BASF SE (DE) | 2015-05-20 | — | — | EP | disclosed |
| EP-2655497-B1 | THERMOPLASTIC MOLDING COMPOSITION | BASF SE (DE) | 2015-03-18 | — | — | EP | disclosed |
| EP-2655496-A1 | THERMOPLASTIC MOLDING COMPOSITION | BASF SE (DE) | 2013-10-30 | — | — | EP | disclosed |
| EP-2655497-A1 | THERMOPLASTIC MOLDING COMPOSITION | BASF SE (DE) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012084777-A1 | THERMOPLASTIC MOLDING COMPOSITION | BASF SE (DE) | 2012-06-28 | — | — | WO | disclosed |
| WO-2012084776-A1 | THERMOPLASTIC MOLDING COMPOSITION | BASF SE (DE) | 2012-06-28 | — | — | WO | disclosed |
| EP-2468812-A1 | Thermoplastic moulding material | BASF SE (DE) | 2012-06-27 | — | — | EP | disclosed |
| EP-2468811-A1 | Thermoplastic moulding material | BASF SE (DE) | 2012-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260121095-A1 | Advanced Ion Exchange Membranes And Applications Thereof | MYOC, MB, MYOF | PPARD 3077/4885TSHR 1922/4885TP53 3017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.